Insulet Announces Positive Clinical Trial Results for Omnipod 6 AID System
Insulet (NASDAQ: PODD) announced positive clinical trial results for its next-generation tubeless Automated Insulin Delivery system, the Omnipod 6. The STRIVE pivotal trial showed improved glycemic outcomes and increased automation in insulin delivery across various age groups and diabetes types.